DGXQUEST DIAGNOSTICS INC

NYSE questdiagnostics.com


$ 144.22 $ 0.61 (0.43 %)    

Friday, 12-Jul-2024 15:59:48 EDT
QQQ $ 494.79 $ 2.89 (0.59 %)
DIA $ 400.37 $ 2.69 (0.68 %)
SPY $ 559.91 $ 3.51 (0.63 %)
TLT $ 93.88 $ 0.40 (0.43 %)
GLD $ 223.10 $ -0.14 (-0.06 %)
$ 144.11
$ 143.84
$ 0.00 x 0
$ 0.00 x 0
$ 143.49 - $ 145.21
$ 116.97 - $ 145.22
581,878
na
16.01B
$ 0.77
$ 18.92
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-24-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 10-25-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-28-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 10-21-2022 09-30-2022 10-Q
8 07-22-2022 06-30-2022 10-Q
9 04-22-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 10-22-2021 09-30-2021 10-Q
12 07-23-2021 06-30-2021 10-Q
13 04-23-2021 03-31-2021 10-Q
14 02-22-2021 12-31-2020 10-K
15 10-23-2020 09-30-2020 10-Q
16 07-24-2020 06-30-2020 10-Q
17 05-04-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 10-23-2019 09-30-2019 10-Q
20 07-24-2019 06-30-2019 10-Q
21 04-24-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 10-24-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-20-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 10-19-2017 09-30-2017 10-Q
28 07-25-2017 06-30-2017 10-Q
29 04-21-2017 03-31-2017 10-Q
30 02-22-2017 12-31-2016 10-K
31 10-21-2016 09-30-2016 10-Q
32 07-25-2016 06-30-2016 10-Q
33 04-27-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 10-29-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 10-30-2014 09-30-2014 10-Q
40 07-31-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 quest-diagnostics-to-acquire-outreach-laboratory-services-of-ohiohealth-financial-details-of-the-transaction-were-not-disclosed

Goal to broaden access to cost-effective and innovative laboratory services in OhioSECAUCUS, N.J. and COLUMBUS, Ohio, July 10, ...

 citigroup-upgrades-quest-diagnostics-to-buy-raises-price-target-to-165

Citigroup analyst Patrick Donnelly upgrades Quest Diagnostics (NYSE:DGX) from Neutral to Buy and raises the price target fro...

 baird-maintains-neutral-on-quest-diagnostics-raises-price-target-to-153

Baird analyst Eric Coldwell maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $145 to $...

 jp-morgan-maintains-neutral-on-quest-diagnostics-raises-price-target-to-155

JP Morgan analyst Lisa Gill maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $152 to $...

 employers-struggle-with-drug-test-policies-amid-varying-state-laws-cheating-on-drug-tests-reaches-30-year-high

Cheating on drug tests among American workers has reached a 30-year high, with Quest Diagnostics Inc. reporting 31,000 tampered...

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 barclays-maintains-equal-weight-on-quest-diagnostics-raises-price-target-to-144

Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from...

 citigroup-maintains-neutral-on-quest-diagnostics-raises-price-target-to-145

Citigroup analyst Patrick Donnelly maintains Quest Diagnostics (NYSE:DGX) with a Neutral and raises the price target from $1...